Orthopedic AM To Bioprinting: A 2030â2050 Outlook
A new academic roadmap lays out how orthopedic 3D printing could evolve into clinical bioprinting by 2050 â and what must happen along the way. Authored by Lucian Reclaru and colleagues from Switzerland and Romania, the paper contrasts subtractive CAD/CAM with additive methods and projects an orthopedic future that moves from patient-matched titanium lattices to living, vascularized grafts. This is a state-of-the-field analysis with a strong forecast. They synthesize three decades of AM development â from stereolithography to laser powder bed fusion â and connect it to real orthopedic practice and near-term hospital workflows. Their premise is straightforward. Subtractive CAD/CAM remains excellent for hard, precise components, but wastes material and limits internal geometry. Additive manufacturing enables porous lattices, tuned stiffness, and true patient specificity. In orthopedics, that means better osseointegration and potentially fewer attachments.
Read more.












